Sociodemographic, clinical and pharmacological characteristics associated with the prognosis of patients with SARS-CoV-2 infection (Características sociodemográficas, clínicas y farmacológicas asociadas con el pronóstico en pacientes con infección por SARS-CoV-2)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/39853
• EU PAS number:
  EUPAS37205
• Study ID:
  39853
• Official title and acronym:
  Sociodemographic, clinical and pharmacological characteristics associated with the prognosis of patients with SARS-CoV-2 infection (Características sociodemográficas, clínicas y farmacológicas asociadas con el pronóstico en pacientes con infección por SARS-CoV-2)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  Study to assess the sociodemographic, clinical and pharmacological characteristics of patients with COVID19 in Catalonia, Spain, with data from SIDIAP database.
• Study status:
  Finalised

Research institution and networks

Institutions

Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGol

Spain

Contact details

Giner-Soriano Maria

Study contact

[e-mail]

Morros Pedrós Rosa

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned: 04/05/2020

Actual: 01/06/2020

Data collection

Planned: 01/06/2020

Actual: 10/08/2020

Start date of data analysis

Planned: 21/09/2020

Actual: 31/10/2020

Date of final study report

Planned: 30/11/2020

Actual: 31/12/2020

Sources of funding

Other

More details on funding

IDIAPJGol

Study protocol

Initial protocol

Covid_idiap_202009

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable